Barbara A. Brown

Skin, Soft Tissue, and Bone Infections Due to Mycobacterium chelonae chelonae: Importance of Prior Corticosteroid Therapy, Frequency of Disseminated Infections, and Resistance to Oral Antimicrobials Other than Clarithromycin

R. J. Wallace, Barbara A. Brown, G O Onyi · The Journal of Infectious Diseases · 1992 · 361 citations

Medicine, Infectious Diseases, Microbiology +17

Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms

Barbara A. Brown, Richard J. Wallace, G O Onyi et al. · Antimicrobial Agents and Chemotherapy · 1992 · 309 citations

Life Sciences, Infectious Diseases, Microbiology +11

Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus

Richard J. Wallace, A Meier, Barbara A. Brown et al. · Antimicrobial Agents and Chemotherapy · 1996 · 287 citations · Full text

Life Sciences, Genetics, Microbiology +17

Clarithromycin Regimens for Pulmonary Mycobacterium Avium Complex. The First 50 Patients

R J Wallace, Barbara A. Brown, David E. Griffith et al. · American Journal of Respiratory and Critical Care Medicine · 1996 · 258 citations

Medicine, Infectious Diseases, Microbiology +13

A Single 16S Ribosomal RNA Substitution Is Responsible for Resistance to Amikacin and Other 2‐Deoxystreptamine Aminoglycosides in<i>Mycobacterium abscessus</i>and<i>Mycobacterium chelonae</i>

Therdsak Prammananan, Peter Sander, Barbara A. Brown et al. · The Journal of Infectious Diseases · 1998 · 230 citations

Life Sciences, Infectious Diseases, Microbiology +17